Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCTET-CY: Cyclophosphamide as Sole GvHD Prophylaxis
NCT01283776Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Mar 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in graft-versus-host disease (GVHD), sponsored by University of Cologne. Started Mar 2011; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01283776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283776.